Advanced Tools Provide Better Solutions for Critical Aspect of Biologics Development Scaling up biologics production from the bench to clinical and commercial scale is a central consideration of ...
Process development is the exercise of creating new and improved manufacturing methods, optimizing them in terms of time and financial efficiency while maintaining regulatory compliance and product ...
Cell and gene therapies offer hope for previously untreatable diseases, with viral vectors currently favored as the primary gene delivery method. To meet patient needs, reliable and cost-effective ...
Thought LeadersAndrew Kennedy & Jono WestVice President, Head of Scale-up & SafetySai Life Sciences In this interview, News-Medical talks to Andrew Kennedy and Jono West from Sai Life Sciences, about ...
If you’ve proven your product on a pilot line, and it’s time to turn up real-world production, beware because many companies stumble on their first large-scale build. Before you pour concrete or sign ...
MONTPELLIER, France & TOULOUSE, France--(BUSINESS WIRE)--Emercell SAS (Emercell) and Cell-Easy SAS (Cell-Easy) announced today the signing of a strategic agreement for the scale-up and manufacturing ...
Transferring a biologic candidate from the research and development phase to commercial production usually requires increasing the working volume of the upstream bioprocess. During scale-up, process ...
For the first time in history, a pathway for ALD-enhanced materials to be rapidly developed and transitioned from lab-scale to commercial production is available for nearly any application. Until ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback